International Patient Summary Implementation Guide
1.1.0 - CI Build International flag

International Patient Summary Implementation Guide, published by HL7 International / Patient Care. This guide is not an authorized publication; it is the continuous build for version 1.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of and changes regularly. See the Directory of published versions

ValueSet: Vaccines WHO ATC - IPS

Official URL: Version: 1.1.0
Standards status: Trial-use Maturity Level: 2 Computable Name: VaccinesWhoAtcUvIps
Other Identifiers: (use: official)

Copyright/Legal: This artifact includes content from Anatomical Therapeutic Chemical (ATC) classification system. ATC codes are copyright World Health Organization (WHO) Collaborating Centre for Drug Statistics Methodology. Terms & Conditions in

World Health Organization Anatomical Therapeutic Chemical (ATC) classification system. Note: The currently implemented code system and the value set expansion contain only a set of example ATC codes, not the complete code system content.


This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)



Expansion based on codesystem WHO ATC version 2020-05

This value set contains 117 concepts.

1  J07
3      J07AC vaccines
4        J07AC01 antigen
3      J07AD vaccines
4        J07AD01 antigen
3      J07AE vaccines
4        J07AE01, inactivated, whole cell
4        J07AE02, live attenuated
4        J07AE51, combinations with typhoid vaccine, inactivated, whole cell
3      J07AF vaccines
4        J07AF01 toxoid
3      J07AG influenzae B vaccines
4        J07AG01 influenzae B, purified antigen conjugated
4        J07AG51 influenzae B, combinations with toxoids
4        J07AG52 influenzae B, combinations with pertussis and toxoids
4        J07AG53 influenzae B, combinations with meningococcus C, conjugated
3      J07AH vaccines
4        J07AH01 A, purified polysaccharides antigen
4        J07AH02 meningococcal monovalent purified polysaccharides antigen
4        J07AH03 A,C, bivalent purified polysaccharides antigen
4        J07AH04 A,C,Y,W-135, tetravalent purified polysaccharides antigen
4        J07AH05 meningococcal polyvalent purified polysaccharides antigen
4        J07AH06 B, outer membrane vesicle vaccine
4        J07AH07 C, purified polysaccharides antigen conjugated
4        J07AH08 A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
4        J07AH09 B, multicomponent vaccine
4        J07AH10 A, purified polysaccharides antigen conjugated
3      J07AJ vaccines
4        J07AJ01, inactivated, whole cell
4        J07AJ02, purified antigen
4        J07AJ51, inactivated, whole cell, combinations with toxoids
4        J07AJ52, purified antigen, combinations with toxoids
3      J07AK vaccines
4        J07AK01, inactivated, whole cell
3      J07AL vaccines
4        J07AL01, purified polysaccharides antigen
4        J07AL02, purified polysaccharides antigen conjugated
4        J07AL52 purified polysaccharides antigen and haemophilus influenzae, conjugated
3      J07AM vaccines
4        J07AM01 toxoid
4        J07AM51 toxoid, combinations with diphtheria toxoid
4        J07AM52 toxoid, combinations with tetanus immunoglobulin
3      J07AN vaccines
4        J07AN01, live attenuated
3      J07AP vaccines
4        J07AP01, oral, live attenuated
4        J07AP02, inactivated, whole cell
4        J07AP03, purified polysaccharide antigen
4        J07AP10, combinations with paratyphi types
3      J07AR (exanthematicus) vaccines
4        J07AR01 exanthematicus, inactivated, whole cell
3      J07AX bacterial vaccines
3      J07BA vaccines
4        J07BA01, tick borne, inactivated, whole virus
4        J07BA02, Japanese, inactivated, whole virus
4        J07BA03, Japanese, live attenuated
3      J07BB vaccines
4        J07BB01, inactivated, whole virus
4        J07BB02, inactivated, split virus or surface antigen
4        J07BB03, live attenuated
4        J07BB04, virus like particles
3      J07BC vaccines
4        J07BC01 B, purified antigen
4        J07BC02 A, inactivated, whole virus
4        J07BC20
3      J07BD vaccines
4        J07BD01, live attenuated
4        J07BD51, combinations with mumps, live attenuated
4        J07BD52, combinations with mumps and rubella, live attenuated
4        J07BD53, combinations with rubella, live attenuated
4        J07BD54, combinations with mumps, rubella and varicella, live attenuated
3      J07BE vaccines
4        J07BE01, live attenuated
3      J07BF vaccines
4        J07BF01 oral, monovalent, live attenuated
4        J07BF02 oral, trivalent, live attenuated
4        J07BF03, trivalent, inactivated, whole virus
4        J07BF04 oral, bivalent, live attenuated
3      J07BG vaccines
4        J07BG01, inactivated, whole virus
3      J07BH virus diarrhea vaccines
4        J07BH01 virus, live attenuated
4        J07BH02 virus, pentavalent, live, reassorted
3      J07BJ vaccines
4        J07BJ01, live attenuated
4        J07BJ51, combinations with mumps, live attenuated
3      J07BK zoster vaccines
4        J07BK01, live attenuated
4        J07BK02, live attenuated
4        J07BK03, purified antigen
3      J07BL fever vaccines
4        J07BL01 fever, live attenuated
3      J07BM vaccines
4        J07BM01 (human types 6, 11, 16, 18)
4        J07BM02 (human types 16, 18)
4        J07BM03 (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)
3      J07BX viral vaccines
4        J07BX01 vaccines
4        J07BX02 vaccines
3      J07CA and viral vaccines, combined
4        J07CA01
4        J07CA02
4        J07CA03
4        J07CA04 influenzae B and poliomyelitis
4        J07CA05 B-pertussis-tetanus
4        J07CA06 influenzae B-pertussis-poliomyelitis-tetanus
4        J07CA07 B-tetanus
4        J07CA08 influenzae B and hepatitis B
4        J07CA09 influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B
4        J07CA10 A
4        J07CA11 influenzae B-pertussis-tetanus-hepatitis B
4        J07CA12 B
4        J07CA13 influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code